Cardiovascular Evaluation in Young Adults
Introduction to Left Ventricular Hypertrophy
- The American Heart Association recommends screening echocardiogram for individuals with stage 2 hypertension or target-organ damage to assess left ventricular hypertrophy (LVH) 1
- Standard 12-lead ECG can show LVH, ST- and T-wave abnormalities, and other findings that suggest underlying diagnoses when interpreted with imaging results 2
Diagnostic Evaluation
- Echocardiography is the first-line imaging modality for LVH diagnosis, and it can help differentiate physiological hypertrophy from pathological LVH by assessing left ventricular filling patterns, isovolumic relaxation times, and chamber size, according to the American Heart Association and American College of Cardiology 3, 1, 2
- If echocardiography confirms LVH, 24-hour ambulatory ECG monitoring should be performed to detect ventricular tachycardia and identify patients who may be candidates for further intervention, as recommended by the American College of Cardiology 4
- A comprehensive assessment should include maximum LV wall thickness measurement, distribution pattern of hypertrophy, assessment of LV outflow tract obstruction, mitral valve function evaluation, left atrial size measurement, and LV systolic and diastolic function 2
- Transthoracic echocardiography (TTE) is the cornerstone of initial evaluation for suspected HCM, assessing maximum left ventricular wall thickness, presence and degree of left ventricular outflow tract obstruction (LVOTO), mitral valve function, left atrial size, and left ventricular systolic and diastolic function 5
Limitations of ECG Criteria
- ECG criteria for LVH have low sensitivity (6-50%) compared to imaging (85-100%), especially in young individuals, highlighting the importance of further evaluation with echocardiography or other imaging modalities 1
- The American College of Cardiology recommends a multimodality approach with echocardiography as the cornerstone diagnostic test, supplemented by electrocardiography and, when necessary, cardiac magnetic resonance imaging (CMR) for the diagnosis of LVH 3, 2
- The European Heart Journal suggests diagnostic criteria for LVH, including LV wall thickness ≥15 mm in one or more myocardial segments in adults, ≥13 mm for first-degree relatives of patients with HCM, and >2 standard deviations above predicted mean (z-score >2) for children 2
Advanced Imaging and Testing
- CMR is indicated when echocardiography is inconclusive or technically limited, suspected apical hypertrophy, need for precise assessment of LV wall thickness and mass, and assessment of myocardial fibrosis/scarring, according to the American College of Cardiology 3
- CMR has advantages including superior spatial resolution, sharp contrast between blood and myocardium, tomographic imaging of entire LV myocardium, and late gadolinium enhancement (LGE) to detect myocardial fibrosis 3
- Exercise echocardiography is recommended if resting echocardiogram does not show significant LVOTO (≥50 mm Hg) to assess for provocable LVOTO, evaluate exercise capacity, and correlate symptoms with cardiac findings 5
- Pulmonary function testing with bronchodilator response and cardiopulmonary exercise testing (CPET) are recommended to differentiate between cardiac and pulmonary causes of exercise intolerance and assess oxygen consumption (VO2) and ventilatory efficiency 5
Follow-up and Risk Stratification
- The initial assessment should include 12-lead ECG and comprehensive transthoracic echocardiography, with follow-up recommendations including repeat echocardiography every 1-2 years in confirmed HCM and annual 12-lead ECG to evaluate for asymptomatic changes in conduction or rhythm 3, 4
- Repeat echocardiography is recommended every 1-2 years to monitor disease progression in patients with confirmed HCM 5
- Risk stratification for sudden cardiac death is recommended in patients with confirmed HCM 5
- Genetic testing should be considered if echocardiography confirms HCM, especially in young patients 5
Differential Diagnosis and Comorbidities
- The European Heart Journal recommends assessing for other causes of LVH, including hypertension, aortic stenosis, athletic heart, and infiltrative diseases (amyloidosis, Fabry disease) 2
- It is essential to distinguish physiologic from pathologic hypertrophy, such as athletic heart vs. HCM, requiring careful evaluation 2
- Family members of HCM patients should undergo screening with ECG and echocardiography according to age-specific protocols 3, 2
- 24-hour ambulatory blood pressure monitoring is recommended to exclude hypertension as a cause of LVH 6
- Assessment of end-organ damage is recommended if hypertension is present 7